Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-020521
Filing Date
2017-08-16
Accepted
2017-08-16 18:04:26
Documents
1
Period of Report
2017-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9852
  Complete submission text file 0000899243-17-020521.txt   11350
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2501 AERIAL CENTER PARKWAY SUITE 205 MORRISVILLE NC 27560
Business Address
D'Alonzo Thomas (Reporting) CIK: 0001382542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 171037309